Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-02

Clinical Trial Update: Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens

View source ↗

Summary

A clinical trial comparing nursing and pharmacy care between capecitabine and 5-fluorouracil regimens for gastric cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Capecitabine (capecitabine)

Snippet

Sponsor: Vivian Wing Yan Lee | Conditions: Gastric Cancer | Status: WITHDRAWN